There were 114 press releases posted in the last 24 hours and 403,535 in the last 365 days.

National Holdings’ National Securities Corporation Rebrands its Healthcare Business as OPN Capital Markets

OPN Capital Markets Launches its Biotech Equity Research Team with a Key Healthcare Hire

NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"), a full-service investment banking and asset management firm, today announced that the Company’s healthcare related investment banking and research businesses will operate under the name OPN Capital Market.

Robert B. Fagenson, the Company’s Vice Chairman and Chief Executive Officer, stated, “The rebranding of our healthcare related businesses is the first step on our journey to further develop our capabilities in the capital markets space. Our plan is to expand on the Company’s biotech and life science investment banking business and turn it into a leader in the field, while also identifying important additional verticals to broaden our product offerings for our clientele.”

In addition, OPN Capital Markets announced the hiring of Jonathan Aschoff, Ph.D. as a Managing Director and Senior Biotechnology Analyst. Previously, Dr. Aschoff was a Managing Director and Senior Biotechnology Analyst at Brean Capital, LLC from 2003 to 2016. Prior to Brean, Dr. Aschoff held positions as a senior biotechnology analyst at Friedman Billings Ramsey & Co., Inc., senior analyst at what is now RBC Dain Rauscher, Inc. and also served as an analyst at Sturza Institutional Research. Prior to beginning his career on Wall Street, Dr. Aschoff earned his Ph.D. in Molecular Biology and Microbiology as well as his B.S. in Biology at Tufts University.

“Dr. Aschoff brings a wealth of knowledge and experience to OPN Capital Markets and provides us with an exceptional base in healthcare research, upon which we can build out our platform.  He has been previously recognized by both Forbes and The Wall Street Journal as a top research analyst in the biotechnology sector and we look forward to the contributions he will make to our organization,” stated Mr. Fagenson.

About National Holdings Corporation

National Holdings Corporation is a full-service investment banking and asset management firm that provides a range of services, including independent retail brokerage and advisory services, investment banking, institutional sales and trading and equity research, financial planning, market making, tax preparation, insurance and annuities, to corporations, institutional investors and high net-worth clients. With over 1,100 independent advisors, registered reps, traders and sales associates, the Company is a leading Independent Advisor and Broker services company. National operates through five subsidiaries: National Securities Corporation, vFinance Investments, Inc., National Insurance Corporation, National Asset Management, Inc. and Gilman Ciocia, Inc. The Company’s National Securities subsidiary was founded in 1947. National was organized in 1999 and is headquartered in New York and Florida. For more information, visit


This press release may contain certain forward-looking statements. Any such statements, other than statements of historical fact, are based on management’s current expectations, estimates, projections, beliefs and assumptions about the Company, its current and prospective portfolio investments, and its industry. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the Company’s control, difficult to predict and could cause actual results to differ materially from those expected or forecasted in such forward-looking statements. Actual developments and results are likely to vary materially from these estimates and projections as a result of a number of factors, including those described from time to time in National’s filings with the Securities and Exchange Commission. Such statements speak only as of the time when made, and National undertakes no obligation to update any such forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.


National Holdings Corporation:

Robert Fagenson, Executive Vice Chairman and CEO, Email:, Telephone: +1 212 417 8050

Jenna Bosco, Investor Relations, Email:, Telephone: +1 212 554 4351